What You Should Know:
– Hello Heartthe only digital therapeutics company focused exclusively on heart disease, announced a $ 70M Series D funding round led by Stripes to support its rapid growth in the employer market
– The funding round will specifically support the increase in employer market demand for Hello Heart’s technology as a focus on heart health sharpens. The company has experienced massive growth in the employer market, doubling the number of customers in the last three months alone.
Empowering People to Manage Their Blood Pressure
Heart disease is the leading cause of death in America and nearly half of US adults live with hypertension. To address these disparities, Hello Heart partners with employers to bring their technology to millions of people. Using AI-based technology, Hello Heart empowers people to effectively manage their blood pressure, pulse, medications, and weight, and has proven results published in a peer-reviewed study: JAMA Network Open.
FDA-Cleared Blood Pressure Monitor
The company’s flagship solution is an FDA-cleared blood pressure monitor coupled with an app. The app empowers people to track their blood pressure, pulse, medications, weight and activity using AI-based technology. The app provides real-time alerts to extremely high readings and encourages users to reach out to their physicians and healthcare professionals to catch risk in time. Looking ahead, Hello Heart intends to deepen the use cases of their artificial intelligence (AI) engines to help manage heart health, which will include enhancing lifestyle digital coaching modules, and adding whole heart health functionality such as deeper medication tracking capabilities, cholesterol tracking and hyperlipidemia digital coaching.
The focus on prioritizing heart health has intensified in light of the Surgeon General’s Call to Action to improve hypertension control across the United States and the CDC’s recommendation that employers should now provide coverage for automated home blood pressure monitors. As a result, Hello Heart is seeing a significant increase in demand for heart health solutions. The company doubled the number of employer clients they serve in the last couple of months alone. Hello Heart’s solution is now available to millions of members. The Hello Heart app has shown the highest engagement rate in the category, with sustained long-term app engagement.
A study recently published in JAMA Network Open * analyzed data from over 28,000 Hello Heart users (see more details and study limitations in source 1). One year post-enrollment, reduced median systolic blood pressure was observed in over 85% of users who had Stage 2 hypertension at baseline. Greater engagement with the app was associated with lower systolic blood pressure over time.
The Validation Institute (see more details and study limitations in source 2) issued a report ** validating Hello Heart’s cost savings and return on investment (ROI) methodology, demonstrating a reduction of total employer medical spend by an average of $ 1,865 per participant per year.
“Hypertension affects 47% of Americans, and heart health in some ways touches all of us. Everyone has a family member or colleague that is affected by heart disease. We empower people to understand, manage, and self-improve their heart health using the app technology and behavioral science, ”said Maayan Cohen, Co-Founder and CEO of Hello Heart. “We make it easy for employers to work with Hello Heart, and it just works. We are thrilled to be working with so many of the nation’s leading employers as they empower their employees to make smart and healthy choices. ”